Study to Determine if Olmesartan Medoxomil Has the Potential to Benefit the Cardiovascular System in Terms of Arterial Protection

Clinical trial NCT00676845 · COMPLETED

Trial details

NCT number: NCT00676845
Sponsor: Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Metabolic Syndrome Hypertension

Start date: 2008-08-01
Primary completion: 2011-05-01
Enrollment: 133

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.